J Breast Cancer.  2014 Sep;17(3):189-199. 10.4048/jbc.2014.17.3.189.

A Review of Breast Cancer Survivorship Issues from Survivors' Perspectives

Affiliations
  • 1Department of Surgery, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
  • 2Breast Cancer Center, National Cancer Center, Goyang, Korea.
  • 3Department of Food and Nutrition, Sookmyung Women's University, Seoul, Korea.
  • 4Department of Psychology, Pusan National University School of Medicine, Busan, Korea.
  • 5Department of Advertising and Branding, Kaywon University of Art and Design, Uiwang, Korea.
  • 6Department of Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea.
  • 7Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 8Department of Surgery, Chonbuk National University Medical School, Jeonju, Korea.
  • 9Department of Surgery, Ajou University School of Medicine, Suwon, Korea.
  • 10Saint Louis University School of Medicine, St. Louis, Missouri, USA.
  • 11Department of Surgery, Soonchunhyang University College of Medicine, Seoul, Korea. min@sch.ac.kr

Abstract

Despite the fact that more breast cancer survivors are currently enjoying longer lifespans, there remains limited knowledge about the factors and issues that are of greatest significance for these survivors, particularly from their perspectives. This review was based on the concept that the topics addressed should focus on the perspectives of current survivors and should be extended to future modalities, which physicians will be able to use to gain a better understanding of the hidden needs of these patients. We intended to choose and review dimensions other than the pathology and the disease process that could have been overlooked during treatment. The eight topics upon which we focused included: delay of treatment and survival outcome; sexual well-being; concerns about childbearing; tailored follow-up; presence of a family history of breast cancer; diet and physical activity for survivors and their families; qualitative approach toward understanding of breast cancer survivorship, and; mobile health care for breast cancer survivors. Through this review, we aimed to examine the present clinical basis of the central issues noted from the survivors' perspectives and suggest a direction for future survivorship-related research.

Keyword

Breast neoplasms; Quality of life; Survivors

MeSH Terms

Breast Neoplasms*
Diet
Follow-Up Studies
Humans
Motor Activity
Pathology
Quality of Life
Survival Rate*
Survivors
Telemedicine

Cited by  2 articles

Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients
Yura Lee, Yu Rang Park, Ji Sung Lee, Sae Byul Lee, Il Yong Chung, Byung Ho Son, Sei Hyun Ahn, Jong Won Lee
J Breast Cancer. 2019;22(1):86-95.    doi: 10.4048/jbc.2019.22.e14.

Polarization of cancer patient management
Ku Sang Kim
J Korean Med Assoc. 2017;60(3):223-227.    doi: 10.5124/jkma.2017.60.3.223.


Reference

1. Hewitt ME, Ganz P. From Cancer Patient to Cancer Survivor: Lost in Transition: an American Society of Clinical Oncology and Institute of Medicine Symposium. Washington, DC: National Academies Press;2006. p. 23–24.
2. Survivorship definitions. 2014. Office of Cancer Survivorship. 2014. Accessed August 25th, 2014. http://cancercontrol.cancer.gov/ocs/statistics/definitions.html.
3. Kappel ML. It's not the model that matters: still lost in transition. J Oncol Pract. 2013; 9:128–129.
4. Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012; 23:2731–2737.
Article
5. Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013; 20:2468–2476.
Article
6. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011; 253:779–785.
7. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013; 148:516–523.
Article
8. Vujovic O, Yu E, Cherian A, Perera F, Dar AR, Stitt L, et al. Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009; 75:771–774.
Article
9. Brazda A, Estroff J, Euhus D, Leitch AM, Huth J, Andrews V, et al. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010; 17:Suppl 3. 291–296.
Article
10. Mujar M, Dahlui M, Yip CH, Taib NA. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival? Prev Med. 2013; 56:222–224.
Article
11. Eastman A, Tammaro Y, Moldrem A, Andrews V, Huth J, Euhus D, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013; 20:1880–1885.
Article
12. Kim K, Chie EK, Han W, Noh DY, Ha SW. Impact of delayed radiotherapy on local control in node-negative breast cancer patients treated with breast-conserving surgery and adjuvant radiotherapy without chemotherapy. Tumori. 2011; 97:341–344.
Article
13. Barbieri V, Sanpaolo P, Genovesi D. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience. Clin Breast Cancer. 2011; 11:114–120.
Article
14. Karlsson P, Cole BF, Colleoni M, Roncadin M, Chua BH, Murray E, et al. Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy. Int J Radiat Oncol Biol Phys. 2011; 80:398–402.
Article
15. Barry PN, Riley EC, Pan J, Crew JB, Lee K, Jain D, et al. Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysis. Am J Clin Oncol. Epub 2013 Mar 4. http://dx.doi.org/10.1097/COC.0b013e318280d79f.
Article
16. Baena-Cañada JM, Rosado-Varela P, Estalella-Mendoza S, Expósito-Álvarez I, González-Guerrero M, Benítez-Rodríguez E. Influence of clinical and biographical factors on the delay in starting adjuvant chemotherapy treatment among breast cancer patients. Med Clin (Barc). 2013; 140:444–448.
17. Lamb MA. Effects of cancer on the sexuality and fertility of women. Semin Oncol Nurs. 1995; 11:120–127.
Article
18. Dizon DS. Quality of life after breast cancer: survivorship and sexuality. Breast J. 2009; 15:500–504.
Article
19. Krychman ML, Pereira L, Carter J, Amsterdam A. Sexual oncology: sexual health issues in women with cancer. Oncology. 2006; 71:18–25.
Article
20. Ochsenkühn R, Hermelink K, Clayton AH, von Schönfeldt V, Gallwas J, Ditsch N, et al. Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder. J Sex Med. 2011; 8:1486–1494.
Article
21. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol. 2003; 30:799–813.
Article
22. Krebs LU. Sexual health during cancer treatment. Adv Exp Med Biol. 2012; 732:61–76.
Article
23. Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004; 22:1849–1856.
Article
24. Gallo-Silver L. The sexual rehabilitation of persons with cancer. Cancer Pract. 2000; 8:10–15.
Article
25. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004; 22:4174–4183.
Article
26. Thewes B, Meiser B, Taylor A, Phillips KA, Pendlebury S, Capp A, et al. Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol. 2005; 23:5155–5165.
Article
27. Holleb AI. Breast cancer and pregnancy. CA Cancer J Clin. 1965; 15:182–183.
Article
28. Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011; 47:74–83.
Article
29. de Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD. Pregnancy after breast cancer: a comprehensive review. J Surg Oncol. 2010; 101:534–542.
Article
30. Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer. 2003; 98:1131–1140.
Article
31. Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007; 334:194.
Article
32. Azim HA Jr, Peccatori FA, de Azambuja E, Piccart MJ. Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther. 2011; 11:287–298.
Article
33. Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast. 2007; 16:Suppl 2. S175–S181.
Article
34. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24:2917–2931.
Article
35. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol. 2006; 24:5769–5779.
Article
36. Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010; 94:638–644.
Article
37. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31:2500–2510.
Article
38. Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol. 2010; 28:4683–4686.
Article
39. Porcu E, Bazzocchi A, Notarangelo L, Paradisi R, Landolfo C, Venturoli S. Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes. 2008; 15:529–535.
Article
40. West ER, Shea LD, Woodruff TK. Engineering the follicle microenvironment. Semin Reprod Med. 2007; 25:287–299.
Article
41. Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, et al. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007; 25:332–337.
Article
42. Dalberg K, Mattsson A, Sandelin K, Rutqvist LE. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat. 1998; 49:69–78.
Article
43. Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, et al. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA. 1999; 281:1586.
Article
44. Oltra A, Santaballa A, Munárriz B, Pastor M, Montalar J. Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective study. Breast J. 2007; 13:571–574.
Article
45. Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009; 13:2–8.
Article
46. American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol. 1997; 15:2149–2156.
47. Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005; 43:592–599.
Article
48. Jung YS, Na KY, Kim KS, Ahn SH, Lee SJ, Park HK, et al. Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer. 2011; 14:229–236.
Article
49. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996; 77:2318–2324.
Article
50. Stratton MR, Rahman N. The emerging landscape of breast cancer susceptibility. Nat Genet. 2008; 40:17–22.
Article
51. Kang DH, Kim SW, Noh DY, Ahn YO, Ryu KY. Epidemiology of breast cancer. Korean Breast Cancer Society. The Breast. 2nd ed. Seoul: Ilchokak;2005. p. 168–188.
52. Han SA, Park SK, Ahn SH, Son BH, Lee MH, Choi DH, et al. The breast and ovarian cancer risks in Korea due to inherited mutations in BRCA1 and BRCA2: a preliminary report. J Breast Cancer. 2009; 12:92–99.
Article
53. Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, et al. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Breast Cancer Res Treat. 2012; 133:1143–1152.
Article
54. Han SA, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, et al. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. Fam Cancer. 2013; 12:75–81.
Article
55. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98:1767–1776.
Article
56. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007; 298:289–298.
Article
57. Kroenke CH, Fung TT, Hu FB, Holmes MD. Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol. 2005; 23:9295–9303.
Article
58. Kwan ML, Weltzien E, Kushi LH, Castillo A, Slattery ML, Caan BJ. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009; 27:919–926.
Article
59. Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, et al. Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev. 2011; 20:890–899.
Article
60. Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, et al. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011; 128:229–236.
Article
61. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, et al. Soy food intake and breast cancer survival. JAMA. 2009; 302:2437–2443.
Article
62. Vrieling A, Buck K, Seibold P, Heinz J, Obi N, Flesch-Janys D, et al. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer. 2013; 108:188–192.
Article
63. McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer. 2006; 55:132–140.
Article
64. Nechuta S, Caan BJ, Chen WY, Kwan ML, Lu W, Cai H, et al. Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev. 2013; 22:1451–1456.
Article
65. Thomson CA, Rock CL, Thompson PA, Caan BJ, Cussler E, Flatt SW, et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat. 2011; 125:519–527.
Article
66. Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, et al. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005; 23:6631–6638.
Article
67. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008; 26:665–673.
Article
68. Poole EM, Shu X, Caan BJ, Flatt SW, Holmes MD, Lu W, et al. Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2013; 139:529–537.
Article
69. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; 62:243–274.
Article
70. Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013; 14:2407–2412.
Article
71. Jacobs ET, Thomson CA, Flatt SW, Al-Delaimy WK, Hibler EA, Jones LA, et al. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr. 2011; 93:108–117.
Article
72. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res. 2011; 13:R74.
Article
73. Beasley JM, Kwan ML, Chen WY, Weltzien EK, Kroenke CH, Lu W, et al. Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat. 2012; 131:637–643.
Article
74. Shin HR, Boniol M, Joubert C, Hery C, Haukka J, Autier P, et al. Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan. Cancer Sci. 2010; 101:1241–1246.
Article
75. Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007; 25:2270–2273.
Article
76. Borreani C, Miccinesi G, Brunelli C, Lina M. An increasing number of qualitative research papers in oncology and palliative care: does it mean a thorough development of the methodology of research? Health Qual Life Outcomes. 2004; 2:7.
77. Ragin CC. The Comparative Method: Moving beyond Qualitative and Quantitative Strategies. Berkeley: University of California Press;1987. p. 1–18.
78. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995; 311:42–45.
Article
79. Ragin CC. Introduction to qualitative comparative analysis. In : Janoski T, Hicks AM, editors. The Comparative Political Economy of the Welfare State. Cambridge: Cambridge University Press;1994. p. 300–309.
80. Camic PM, Rhodes JE, Yardley L. Naming the stars: integrating qualitative methods into psychological research. In : Camic PM, Rhodes JE, Yardley L, editors. Qualitative Research in Psychology: Expanding Perspectives in Methodology and Design. Washington, DC: American Psychological Association;2003. p. 3–15.
81. Hays DG, Singh AA. Qualitative Inquiry in Clinical and Educational Settings. New York: Guilford Press;2011. p. 3–31.
82. Strang P. Qualitative research methods in palliative medicine and palliative oncology: an introduction. Acta Oncol. 2000; 39:911–917.
Article
83. Roundtree AK, Giordano SH, Price A, Suarez-Almazor ME. Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer. 2011; 19:1921–1929.
Article
84. Lally RM, Underhill ML. Transition to breast cancer survivorship: a longitudinal qualitative follow-up study of two-year survivors. J Psychosoc Oncol. 2012; 30:97–127.
Article
85. Kirkman M, Winship I, Stern C, Neil S, Mann GB, Fisher JR. Women's reflections on fertility and motherhood after breast cancer and its treatment. Eur J Cancer Care (Engl). 2014; 23:502–513.
Article
86. Wang F, Chen F, Huo X, Xu R, Wu L, Wang J, et al. A neglected issue on sexual well-being following breast cancer diagnosis and treatment among Chinese women. PLoS One. 2013; 8:e74473.
Article
87. Kim IR, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, et al. Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J Cancer Prev. 2012; 13:1383–1388.
Article
88. Milberg A, Strang P. Met and unmet needs in hospital-based home care: qualitative evaluation through open-ended questions. Palliat Med. 2000; 14:533–534.
Article
89. Luoma ML, Hakamies-Blomqvist L. The meaning of quality of life in patients being treated for advanced breast cancer: a qualitative study. Psychooncology. 2004; 13:729–739.
Article
90. Ashing-Giwa KT, Padilla G, Tejero J, Kraemer J, Wright K, Coscarelli A, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology. 2004; 13:408–428.
Article
91. Foley KL, Farmer DF, Petronis VM, Smith RG, McGraw S, Smith K, et al. A qualitative exploration of the cancer experience among long-term survivors: comparisons by cancer type, ethnicity, gender, and age. Psychooncology. 2006; 15:248–258.
Article
92. Lee S, Chen L, Ma GX, Fang CY, Oh Y, Scully L. Challenges and needs of Chinese and Korean American breast cancer survivors: in-depth interviews. N Am J Med Sci (Boston). 2013; 6:1–8.
93. De Vries J, Den Oudsten BL, Jacobs PM, Roukema JA. How breast cancer survivors cope with fear of recurrence: a focus group study. Support Care Cancer. 2014; 22:705–712.
Article
94. Thomsen DK, Pedersen AF, Johansen MB, Jensen AB, Zachariae R. Breast cancer patients' narratives about positive and negative communication experiences. Acta Oncol. 2007; 46:900–908.
Article
95. Wright EB, Holcombe C, Salmon P. Doctors' communication of trust, care, and respect in breast cancer: qualitative study. BMJ. 2004; 328:864.
Article
96. Green J, Thorogood N. Qualitative Methods for Health Research. 3rd ed. London: Sage;2013. p. 20.
97. Hefferon K, Murphy H, McLeod J, Mutrie N, Campbell A. Understanding barriers to exercise implementation 5-year post-breast cancer diagnosis: a large-scale qualitative study. Health Educ Res. 2013; 28:843–856.
Article
98. Miedema B, Easley J. Barriers to rehabilitative care for young breast cancer survivors: a qualitative understanding. Support Care Cancer. 2012; 20:1193–1201.
Article
99. Nelson A, Fenlon D, Morris J, Sampson C, Harrop E, Murray N, et al. QUALZICE: a QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates. Trials. 2013; 14:325.
Article
100. Consulting VW. mHealth for Development: the Opportunity of Mobile Technology for Healthcare in the Developing World. Washington, DC: UN Foundation-Vodafone Foundation Partnership;2009.
101. Pal K, Eastwood SV, Michie S, Farmer AJ, Barnard ML, Peacock R, et al. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013; 3:CD008776.
Article
102. de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012; 12:CD007459.
Article
103. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011.
Article
104. Gentry S, van-Velthoven MH, Tudor Car L, Car J. Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection. Cochrane Database Syst Rev. 2013; 5:CD009189.
Article
105. Whittaker R, McRobbie H, Bullen C, Borland R, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2012; 11:CD006611.
Article
106. Marcano Belisario JS, Bruggeling MN, Gunn LH, Brusamento S, Car J. Interventions for recruiting smokers into cessation programmes. Cochrane Database Syst Rev. 2012; 12:CD009187.
Article
107. Ryan D, Cobern W, Wheeler J, Price D, Tarassenko L. Mobile phone technology in the management of asthma. J Telemed Telecare. 2005; 11:Suppl 1. 43–46.
Article
108. Weaver A, Young AM, Rowntree J, Townsend N, Pearson S, Smith J, et al. Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol. 2007; 18:1887–1892.
Article
109. Killingsworth MA, Gilbert DT. A wandering mind is an unhappy mind. Science. 2010; 330:932.
Article
110. Valle CG, Tate DF, Mayer DK, Allicock M, Cai J. A randomized trial of a Facebook-based physical activity intervention for young adult cancer survivors. J Cancer Surviv. 2013; 7:355–368.
Article
111. Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2013; 137:869–882.
Article
112. Patrick K, Griswold WG, Raab F, Intille SS. Health and the mobile phone. Am J Prev Med. 2008; 35:177–181.
Article
113. Ganz PA. Quality of life across the continuum of breast cancer care. Breast J. 2000; 6:324–330.
Article
114. Polaine A, Løvlie L, Reason B. Service Design: from Insight to Implementation. Brooklyn: Rosenfeld Media;2012.
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr